Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug. This was particularly evident among MS patients who took beta interferon for more than three years.

More Posts

scleroseinf cirler

Abboner på YouTube Har du tilmeldt eller abboneret dig på Sclerose.infos YouTube kanal ? Hvis ikke – så klik over og gør det Der kommer mere og

IMG 20230629 234144

Mine Suurballe

Hør og se podcast med Mine SuurballeVi har snakket med Mine Suurballe som opfølgning på hendes podcast i fire dele for nydiagnosticerede med sclerose, der